| Clinical significance of somatic mutation in unexplained blood cytopenia L Malcovati, A Gallì, E Travaglino, I Ambaglio, E Rizzo, E Molteni, C Elena, ... Blood, The Journal of the American Society of Hematology 129 (25), 3371-3378, 2017 | 457 | 2017 |
| Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome E Bono, D McLornan, E Travaglino, S Gandhi, A Gallì, AA Khan, ... Leukemia 33 (10), 2495-2505, 2019 | 83 | 2019 |
| Relationship between clone metrics and clinical outcome in clonal cytopenia A Gallì, G Todisco, E Catamo, C Sala, C Elena, S Pozzi, E Bono, ... Blood, The Journal of the American Society of Hematology 138 (11), 965-976, 2021 | 69 | 2021 |
| Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome N Guzzi, S Muthukumar, M Cieśla, G Todisco, PCT Ngoc, M Madej, ... Nature Cell Biology 24 (3), 299-306, 2022 | 50 | 2022 |
| Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms G Todisco, M Creignou, A Gallì, P Guglielmelli, E Rumi, M Roncador, ... Leukemia 35 (8), 2371-2381, 2021 | 22 | 2021 |
| ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing EM Beauchamp, M Leventhal, E Bernard, ER Hoppe, G Todisco, ... Blood cancer discovery 2 (5), 500-517, 2021 | 21 | 2021 |
| Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics G Todisco, T Manshouri, S Verstovsek, L Masarova, SA Pierce, ... Leukemia & lymphoma 57 (5), 1054-1059, 2016 | 19 | 2016 |
| Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia G Tsaknakis, A Gallì, S Papadakis, P Kanellou, C Elena, G Todisco, ... Blood, The Journal of the American Society of Hematology 138 (14), 1249-1257, 2021 | 15 | 2021 |
| m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis M Cieśla, PCT Ngoc, S Muthukumar, G Todisco, M Madej, H Fritz, ... Molecular Cell 83 (7), 1165-1179. e11, 2023 | 10 | 2023 |
| Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications C Elena, A Gallì, E Bono, G Todisco, L Malcovati Current opinion in hematology 28 (5), 347-355, 2021 | 10 | 2021 |
| SRSF2 Mutations identify a distinct subtype of myeloid neoplasm across myelodysplastic syndromes and acute myeloid leukemia G Todisco, A Gallì, E Travaglino, E Rizzo, E Molteni, C Elena, I Ambaglio, ... Blood 128 (22), 4337, 2016 | 5 | 2016 |
| Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization E Bono, D McLornan, E Travaglino, S Gandhi, A Gallì, AA Khan, ... Blood 130, 588, 2017 | 4 | 2017 |
| Therapy-related myelofibrosis does not appear to exist L Masarova, G Todisco, T Manshouri, KJ Newberry, JE Cortes, ... Blood Advances 1 (14), 863-866, 2017 | 4 | 2017 |
| Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us? G Todisco, PL Moura, E Hellström-Lindberg Seminars in Hematology 59 (3), 150-155, 2022 | 3 | 2022 |
| Integrative Analysis of Primary SF3B1 mt Ring Sideroblasts Provides Fundamental Insights into MDS-RS Pathogenesis and Dyserythropoiesis PL Moura, T Mortera-Blanco, IJF Hofman, G Todisco, WW Kretzschmar, ... Blood 138 (Supplement 1), 146-146, 2021 | 2 | 2021 |
| Predictive value of mutation analysis in the diagnostic approach to patients with unexplained cytopenia L Malcovati, A Gallì, E Travaglino, I Ambaglio, E Rizzo, E Molteni, C Elena, ... Blood 128 (22), 298, 2016 | 2 | 2016 |
| Clinical and genomic-based decision support system to define the optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes … CA Tentori, C Gregorio, M Robin, N Gagelmann, C Gurnari, S Ball, ... Blood 142, 197, 2023 | 1 | 2023 |
| Combining Gene Mutation with Transcriptomic Data Improves Outcome Prediction in Myelodysplastic Syndromes E Sauta, M Zampini, D Dall'Olio, C Sala, G Todisco, E Travaglino, ... Blood 142, 1863, 2023 | 1 | 2023 |
| Erythroid differentiation intensifies RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts PL Moura, T Mortera-Blanco, IJF Hofman, G Todisco, WW Kretzschmar, ... bioRxiv, 2023.04. 11.536355, 2023 | 1 | 2023 |
| Clonal Trajectories and Therapeutic Targeting of High-Risk SF3B1-Mutant Myelodysplastic Syndromes M Sarchi, CA Clough, A Gallì, G Todisco, JP Creamer, L Malcovati, ... Blood 140 (Supplement 1), 211-212, 2022 | 1 | 2022 |
